PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalised and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium; Antwerp University, Universiteitsplein 1, Wilrijk B-2610, Belgium. Electronic address: peter.vandam@uza.be.\', \'Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Antwerp University, Universiteitsplein 1, Wilrijk B-2610, Belgium.\', \'Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, B2650, Belgium; StatUa, Center for Statistics, University of Antwerp, Antwerp, B2000, Belgium.\', \'Molecular Pathology Group, Cell Biology and Histology and Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium.\', \'Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium.\', \'Center for Oncological Research (CORE), Integrated Personalised and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium.\', \'Department of Medical Oncology, AZ Middelares, Ghent, Belgium; Center for Oncological Research (CORE), Integrated Personalised and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium; Antwerp University, Universiteitsplein 1, Wilrijk B-2610, Belgium.\', \'Center for Oncological Research (CORE), Integrated Personalised and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium; Department of Medical Oncology, AZ Middelares, Ghent, Belgium.\', \'Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalised and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium.\', \'Department of Hematology, Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium.\', \'VIB-UGent Center for Medical Biotechnology, Technologiepark, Zwijnaarde 71, B-9052 Ghent, Belgium.\', \'Department Biomedical Sciences, University Antwerp, PPES Lab Protein Chemistry, Proteomics & Epigenetic Signaling, IPPON, Universiteitsplein 1, Wilrijk B-2610, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0959-8049(21)00107-610.1016/j.ejca.2021.02.024
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 33773276
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33773276>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33773276>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all